Diosbulbin D

CAS : 66756-57-8

Ref. 3D-RCA75657

Informations sur le produit

• Nom: Diosbulbin D
• Synonymes: (2S,4aS,6aS,7R,10R,11aR,11bS)-2-(3-Furanyl)octahydro-11b-methyl-7,10-methano-2H-pyrano[4,3-g][3]benzoxepin-4,6,8(1H)-trione, 7,10-Methano-2H-pyrano[4,3-g][3]benzoxepin-4,6,8(1H)-trione, 2-(3-furanyl)octahydro-11b-methyl-, (2S,4aS,6aS,7R,10R,11aR,11bS)-, 7,10-Methano-2H-pyrano[4,3-g][3]benzoxepin-4,6,8(1H)-trione, 2-(3-furanyl)octahydro-11b-methyl-, [2S-(2α,4aβ,6aα,7α,10α,11aβ,11bα)]-, NSC 310637, Neodiosbulbin

Description

Diosbulbin D is a tetrahydrocannabinol (THC) derivative that has been identified as a matrix effect agent. It is a potent, selective and orally active inhibitor of the enzyme fatty acid amide hydrolase (FAAH). Diosbulbin D selectively blocks the hydrolysis of anandamide and other endocannabinoids, which are lipid-signaling molecules produced by the body. This prevents their degradation, leading to increased levels of these compounds in the body. The effects of this drug have been analyzed using LC-MS/MS method on bladder cancer cells, pancreatic cancer cells and skin cancer cells. The results suggest that it may be an effective treatment for cancers characterized by elevated FAAH levels.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 344.4 g/mol
• Formule: C₁₉H₂₀O₆
• Degré de pureté: Min. 95%